28Aug 2018

ROLE OF CANNABIS IN PSYCHIATRIC ILLNESSES: A MINI-LITERATURE REVIEW.

  • Cardiology, Mayo Clinic, Rochester, USA, 802 1st ST SW, Rochester, MN, USA.
  • Cardiology Research Assistant, VA Palo Alto Health Care System, Palo Alto, USA
  • Internal Medicine, Peoples University of Medical and Health Sciences, Nawabshah, Pakistan.
  • Internal Medicine, Harvard Medical College/Beth Israel Deaconess Medical Center, Boston, USA.
  • Chief Extern Cardiology, Heart and Vascular Institute, Detroit Medical Center, MI, US
  • Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, Pakistan
  • MNR Medical College & Hospital, Shapur, India.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Cannabis is one of the most abused illicit drug in the United States. Currently, nine states and D.C has legalized marijuana for recreational use, which will only lead to increased use. About 20% of adolescents report using cannabis at least once per week. Its increased used particularly in individuals below 25 years can affect brain development. Multiple surveys and studies have shown a connection between cannabis use and its harmful effects on human health particularly mental health. Whether cannabis use increases the incidence of psychiatric disorders such as mood or psychotic disorders or exacerbates the already established diseases, in either case, both of them are the cause of substantial distress for individuals and their families, also to public burden from health-care costs. In this paper, we have mentioned some psychiatric illnesses which directly or indirectly are associated with cannabis use. The objective of this study is to offer an up-to-date overview of cannabis use and its effects on mental health. This study would contribute to increased knowledge and improved awareness among people towards cannabis use to discourage its further use to enhance the quality of life, thus eliminating its harmful effects. Whether cannabis use is the direct cause of mental health issues or one of the factors associated with it, is still an open question requiring further research and studies.

  1. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. The Lancet. 2007 Jul 28;370(9584):319-28.
  2. Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies. International Journal of Stroke. 2013 Oct;8(7):545-59- doi:10.1111/j.1747-4949.2012.00906.x
  3. SoaresVde P1, Campos AC, Bortoli VC, Zangrossi H Jr, Guimar?es FS, Zuardi AW. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors. Behav Brain Res. 2010 Dec 1;213(2):225-9. doi: 10.1016/j.bbr.2010.05.004.
  4. Rubino T, Guidali C, Vigano D, Realini N, Valenti M, Massi P, Parolaro D. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology. 2008 Jan 1;54(1):151-60.
  5. Agosti V1, Nunes E, Levin F. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse. 2002 Nov;28(4):643-52
  6. Grant BF Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Abuse. 1995;7(4):481-97.
  7. Chen CY1, Wagner FA, Anthony JC. Marijuana use and the risk of Major Depressive Episode. Epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry PsychiatrEpidemiol. 2002 May;37(5):199-206
  8. Bovasso GB Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry. 2001 Dec;158(12):2033-7.
  9. Fergusson DM1, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction. 1997 Mar;92(3):279-96.
  10. Brook DW1, Brook JS, Zhang C, Cohen P, Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry. 2002 Nov;59(11):1039-44.
  11. Degenhardt L1, Coffey C, Romaniuk H, Swift W, Carlin JB, Hall WD, Patton GC. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction. 2013 Jan;108(1):124-33. doi: 10.1111/j.1360-0443.2012.04015.x. Epub 2012 Oct 18.
  12. Lev-Ran S1, Roerecke M2, Le Foll B3, George TP4, McKenzie K1, Rehm J The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med. 2014 Mar;44(4):797-810. doi: 10.1017/S0033291713001438.
  13. DSM-IV, APATF. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. vol. Washington; 2000, https://doi.org/10.1002/jps.3080051129
  14. Feingold D, Weiser M, Rehm J, Lev-Ran S. The association between cannabis use and mood disorders: A longitudinal study. J Affect Disord. 2015 Feb 1;172:211-8. doi: 10.1016/j.jad.2014.10.006. Epub 2014 Oct 13.
  15. Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP. Cannabis use and mania symptoms: a systematic review and metaanalysis. J Affect Disord 2014;171:39?47, https://doi.org/10.1016/ j.jad.2014.09.016
  16. Ahrnsbrak R, Bose J, Hedden SL, Lipari RN, Park-Lee E.: Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. SAMHSA, Rockville, MD; 2017.
  17. Grinspoon L, Bakalar JB, Zimmer L, Morgan JP: Marijuana addiction. Science. 1997 , 277:749-753. 1126/science.277.5327.749a
  18. Anthony JC, Warner LA, Kessler RC: Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. ExpClinPsychopharmacol. 1994 , 2:244-268. 1037/1064-1297.2.3.244
  19. Budney AJ, Hughes JR: The cannabis withdrawal syndrome. CurrOpin Psychiatry. 2006, 19:233-238. 1097/01.yco.0000218592.00689.e5
  20. Bonnet U, Preuss UW: The cannabis withdrawal syndrome: current insights. Subst Abuse Rehabil. 2017, 8:9-37. 2147/SAR.S109576
  21. Miller NS, Oberbarnscheidt T, Gold MS: Marijuana Addictive Disorders: DSM-5 Substance-Related Disorders. J Addict Res Ther S. 2017, 11:2. 4172/2155-6105.S11-013
  22. Johnson SB, Blum RW, Giedd JN: Adolescent maturity and the brain: the promise and pitfalls of neuroscience research in adolescent health policy. J Adolesc Health. 2009, 45:216-221. 1016%2Fj.jadohealth.2009.05.016
  23. Rubia K, Overmeyer S, Taylor E et al.: Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI. NeurosciBiobehav Rev. 2000, 24:13-19. 1016/S0149-7634(99)00055-X
  24. Fergusson DM, Boden JM: Cannabis use and later life outcomes. Addiction. 2008 , 103:969-976. 1111/j.1360-0443.2008.02221.x
  25. Broyd SJ, van Hell HH, Beale C, Y?cel M, Solowij N: Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. . Biol Psychiatry. 2016, 79:557-567. 1016/j.biopsych.2015.12.002
  26. de Moraes Barros MC, Guinsburg R, Mitsuhiro S, Chalem E, Laranjeira RR: Neurobehavioral profile of healthy full-term newborn infants of adolescent mothers. Early Hum Dev. 2008, 84:281-287. 1016/j.earlhumdev.2007.07.001
  27. Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addiction biology. 2008 Jun;13(2):264-75.
  28. Amar MB, Potvin S. Cannabis and psychosis: what is the link?. Journal of psychoactive drugs. 2007 Jun 1;39(2):131-42.
  29. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Braley G, Gueorguieva R, Krystal JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology. 2004 Aug;29(8):1558.
  30. Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G (2001). Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol cross-sensitization with morphine. Psychopharmacology 158: 259?266.

[Wajih Ullah M, Ashraf F, Samarta Alias Monika F, Siddiq W, Fatiwala Z, Zaheer S and Nimmatoori Dp. (2018); ROLE OF CANNABIS IN PSYCHIATRIC ILLNESSES: A MINI-LITERATURE REVIEW. Int. J. of Adv. Res. 6 (Aug). 1175-1179] (ISSN 2320-5407). www.journalijar.com

MUHAMMAD WAJIH ULLAH
Cardiology Research Fellow, Mayo Clinic, Rochester, USA 802 1st ST SW, Rochester, MN, USA

DOI:

Article DOI: 10.21474/IJAR01/7628      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7628

Download Full Paper

Download PDF No. of Downloads: 18 | No. of Views: 80